Comparative Genomics of Serial Candida glabrata Isolates and the Rapid Acquisition of Echinocandin Resistance during Therapy

Trimmomatic: a flexible trimmer for Illumina sequence data

Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548 · see citing works

The Sequence Alignment/Map format and SAMtools

Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · see citing works

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · see citing works

VariantAnnotation : a Bioconductor package for exploration and annotation of genetic variants

Obenchain, V., Lawrence, M. F., Carey, V. J., Gogarten, S. M., Shannon, P. T., & Morgan, M. T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu168 · Cited by 340 · see citing works

Effect of <i>Candida glabrata FKS1</i> and <i>FKS2</i> Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β- <scp>d</scp> -Glucan Synthase: Implication for the Existing Susceptibility Breakpoint

Garcia-Effron, G., Lee, S., Park, S., Cleary, J. D., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00443-09 · Cited by 323 · see citing works

Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008–2013: results from population-based surveillance

Cleveland, A. A., Harrison, L. H., Farley, M. M., Hollick, R., Stein, B., Chiller, T. M., Lockhart, S. R., & Park, B. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120452 · Cited by 304 · see citing works

Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence

Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · see citing works

Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance.

Healey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., Kontoyiannis, D. P., Sanglard, D., Taj-Aldeen, S. J., Alexander, B. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11128 · Cited by 276 · see citing works

Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance

Pham, C. D., Iqbal, N., Bolden, C. B., Kuykendall, R. J., Harrison, L. H., Farley, M. M., Schaffner, W., Beldavs, Z. G., Chiller, T. M., Park, B. J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03255-14 · Cited by 231 · see citing works

Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata

Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 204 · see citing works

Comparative genomics of emerging pathogens in the Candida glabrata clade.

Gabaldón, T., Martin, T., Marcet-Houben, M., Durrens, P., Bolotin-Fukuhara, M., Lespinet, O., Arnaise, S., Boisnard, S., Aguileta, G., Atanasova, R., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-623 · Cited by 198 · see citing works

The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling.

Reinoso-Martín, C., Schüller, C., Schuetzer-Muehlbauer, M., & Kuchler, K. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.6.1200-1210.2003 · Cited by 193 · see citing works

Multilocus Sequence Typing of Candidaglabrata Reveals Geographically EnrichedClades

Dodgson, A. R., Pujol, C., Denning, D. W., Soll, D. R., & Fox, A. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5709-5717.2003 · Cited by 191 · see citing works

Analysis of β-1,3-Glucan Assembly in Saccharomyces cerevisiae Using a Synthetic Interaction Network and Altered Sensitivity to Caspofungin

Lesage, G., Sdicu, A.-M., Ménard, P., Shapiro, J., Hussein, S., & Bussey, H. (2004) · Genetics · doi:10.1534/genetics.167.1.35 · Cited by 166 · see citing works

Patterns of Genomic Variation in the Opportunistic Pathogen Candida glabrata Suggest the Existence of Mating and a Secondary Association with Humans

Carreté, L., Ksiezopolska, E., Pegueroles, C., Gómez-Molero, E., Saus, E., Iraola-Guzmán, S., Loska, D., Bader, O., Fairhead, C., & Gabaldón, T. (2018) · Current Biology · doi:10.1016/j.cub.2017.11.027 · Cited by 118 · see citing works

Adhesins in Candida glabrata

Timmermans, B., De Las Peñas, A., Castaño, I., & Van Dijck, P. (2018) · Journal of Fungi · doi:10.3390/jof4020060 · Cited by 109 · see citing works

Genetic Drivers of Multidrug Resistance in Candida glabrata

Healey, K. R., Jimenez Ortigosa, C., Shor, E., & Perlin, D. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01995 · Cited by 93 · see citing works

Proteomics of drug resistance in <i>Candida glabrata</i> biofilms

Seneviratne, C. J., Wang, Y., Jin, L., Abiko, Y., & Samaranayake, L. P. (2010) · PROTEOMICS · doi:10.1002/pmic.200900611 · Cited by 74 · see citing works

Tipping the balance both ways: drug resistance and virulence in Candida glabrata

Vale-Silva, L. A., & Sanglard, D. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov025 · Cited by 68 · see citing works

Comparative Genomics of Two Sequential <i>Candida glabrata</i> Clinical Isolates

Vale-Silva, L., Beaudoing, E., Tran, V. D. T., & Sanglard, D. (2017) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.117.042887 · Cited by 61 · see citing works

Isavuconazole and Nine Comparator Antifungal Susceptibility Profiles for Common and Uncommon Candida Species Collected in 2012: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values

Castanheira, M., Messer, S. A., Rhomberg, P. R., Dietrich, R. D., Jones, R. N., & Pfaller, M. A. (2014) · Mycopathologia · doi:10.1007/s11046-014-9772-2 · Cited by 46 · see citing works

Gross karyotypic and phenotypic alterations among different progenies of the Candida glabrata CBS138/ATCC2001 reference strain

Bader, O., Schwarz, A., Kraneveld, E. A., Tangwattanchuleeporn, M., Schmidt, P., Jacobsen, M. D., Gross, U., De Groot, P. W. J., & Weig, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052218 · Cited by 39 · see citing works

The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens

Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145 · see citing works

Genome Comparisons of Candida glabrata Serial Clinical Isolates Reveal Patterns of Genetic Variation in Infecting Clonal Populations

Carreté, L., Ksiezopolska, E., Gómez-Molero, E., Angoulvant, A., Bader, O., Fairhead, C., & Gabaldón, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00112 · Cited by 58 · see citing works

Recent gene selection and drug resistance underscore clinical adaptation across Candida species

Schikora-Tamarit, M. À., & Gabaldón, T. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01547-z · Cited by 54 · see citing works

De novo genome assembly of Candida glabrata reveals cell wall protein complement and structure of dispersed tandem repeat arrays

Xu, Z., Green, B., Benoit, N. E., Schatz, M. C., Wheelan, S. J., & Cormack, B. P. (2020) · Molecular Microbiology · doi:10.1111/mmi.14488 · Cited by 45 · see citing works

Opportunistic yeast pathogen Candida spp.: Secreted and membrane-bound virulence factors.

Lim, S. J., Ali, M., Sabri, S., Noor, N. D. M., Salleh, A., & Oslan, S. N. (2021) · Medical Mycology · doi:10.1093/mmy/myab053 · Cited by 40 · see citing works

Emergence of resistantCandida glabratain Germany

Aldejohann, A. M., Herz, M., Martin, R., Walther, G., & Kurzai, O. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab122 · Cited by 41 · see citing works

Antifungal Susceptibility of Clinical Yeast Isolates from a Large Canadian Reference Laboratory and Application of Whole-Genome Sequence Analysis To Elucidate Mechanisms of Acquired Resistance

McTaggart, L. R., Cabrera, A. L., Cronin, K. I., & Kus, J. V. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00402-20 · Cited by 35 · see citing works

Using genomics to understand the mechanisms of virulence and drug resistance in fungal pathogens

Schikora-Tamarit, M. À., & Gabaldón, T. (2022) · Biochemical Society Transactions · doi:10.1042/bst20211123 · Cited by 30 · see citing works

Cell wall protein variation, break‐induced replication, and subtelomere dynamics in Candida glabrata

Xu, Z., Green, B., Benoit, N. E., Sobel, J. D., Schatz, M. C., Wheelan, S. J., & Cormack, B. P. (2021) · Molecular Microbiology · doi:10.1111/mmi.14707 · Cited by 27 · see citing works

Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets

Helmstetter, N., Chybowska, A. D., Delaney, C., Dantas, A. D. S., Gifford, H., Wacker, T., Munro, C. A., Warris, A., Jones, B. L., Cuomo, C. A., et al. (2022) · Genetics · doi:10.1093/genetics/iyac031 · Cited by 29 · see citing works

Antifungal stewardship with an emphasis on candidaemia

Capoor, M. R., Subudhi, C. P. K., Collier, A., & Bal, A. M. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.05.030 · Cited by 27 · see citing works

A Noncanonical DNA Damage Checkpoint Response in a Major Fungal Pathogen

Shor, E., Garcia‐Rubio, R., DeGregorio, L., & Perlin, D. S. (2020) · mBio · doi:10.1128/mbio.03044-20 · Cited by 23 · see citing works

In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains

Aldejohann, A. M., Menner, C., Thielemann, N., Martin, R., Walther, G., & Kurzai, O. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01324-23 · Cited by 20 · see citing works

Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates

Misas, E., Seagle, E. E., Jenkins, E. N., Rajeev, M., Hurst, S. F., Nunnally, N. S., Bentz, M. L., Lyman, M., Berkow, E. L., Harrison, L. H., et al. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.01140-23 · Cited by 18 · see citing works

Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinants

Pais, P., Galocha, M., Takahashi‐Nakaguchi, A., Chibana, H., & Teixeira, M. C. (2022) · Microbial Cell · doi:10.15698/mic2022.11.786 · Cited by 15 · see citing works

The Emergence of Echinocandin-Resistant Candida glabrata Exhibiting High MICs and Related FKS Mutations in Turkey

Sığ, A. K., Sönmezer, M. Ç., Gülmez, D., Duyan, S., Uzun, Ö., & Arıkan-Akdağlı, S. (2021) · Journal of Fungi · doi:10.3390/jof7090691 · Cited by 14 · see citing works

DNA damage response of major fungal pathogen Candida glabrata offers clues to explain its genetic diversity

Shor, E., & Perlin, D. S. (2021) · Current Genetics · doi:10.1007/s00294-021-01162-7 · Cited by 12 · see citing works

Evolutionary dynamics in gut-colonizing Candida glabrata during caspofungin therapy: Emergence of clinically important mutations in sphingolipid biosynthesis

Hassoun, Y., Aptekmann, A. A., Keniya, M. V., Gomez, R. Y., Alayo, N., Novi, G., Quinteros, C., Kaya, F., Zimmerman, M. D., Caceres, D. H., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012521 · Cited by 11 · see citing works

Candida glabrata hospital isolate from Lebanon reveals micafungin resistance associated with increased chitin and resistance to a cell-surface-disrupting agent

Fattouh, N., Khalaf, R. A., & Husni, R. (2024) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2024.02.012 · Cited by 9 · see citing works

Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.

Agnelli, C., Guinea, J., Valerio, M., Escribano, P., Bouza, E., & Muñóz, P. (2019) · PubMed Central · Cited by 7 · see citing works

Experimental Evolution of Multidrug Resistance in Neurospora crassa under Antifungal Azole Stress

Zhou, M., Hu, C., Yin, Y., Wang, J., Ye, S., Yu, Y., Sun, X., & Li, S. (2022) · Journal of Fungi · doi:10.3390/jof8020198 · Cited by 6 · see citing works

A multidimensional assessment of in-host fitness costs of drug resistance in the opportunistic fungal pathogen Candida glabrata

Arastehfar, A. A., Daneshnia, F., Hovhannisyan, H., Cabrera, N., İlkit, M., Desai, J. V., Gabaldón, T., Shor, E., & Perlin, D. S. (2024) · FEMS Yeast Research · doi:10.1093/femsyr/foae035 · Cited by 6 · see citing works

Expression of 1,3-β-glucan synthase subunits in <i>Candida glabrata</i> is regulated by the cell cycle and growth conditions and at both transcriptional and post-transcriptional levels

Gonzalez-Jimenez, I., Keniya, M. V., Aptekmann, A. A., Quinteros, C., Wilkerson, A., Arastehfar, A., Daneshnia, F., Perlin, D. S., & Shor, E. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00500-25 · Cited by 4 · see citing works

Phylogenomic analysis and genetic mechanisms of antifungal resistance in clinical isolates of Candida glabrata ( Nakaseomyces glabratus ) from across Canada, 2013–2020

Luca, D. G. D., Alexander, D. C., Dingle, T. C., Dufresne, P. J., Fuller, J., German, G. J., Haldane, D. J. M., Hoang, L., Jiao, L., Kus, J. V., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01803-25 · Cited by 3 · see citing works

Caspofungin enhances antifungal immunity in human blood through transcriptional reprogramming

Shehata, A., Schäuble, S., Martin, R., Aldejohann, A. M., Panagiotou, G., Kurzai, O., & Hünniger, K. (2026) · microLife · doi:10.1093/femsml/uqag004 · Cited by 2 · see citing works

Suppressed Protein Translation Caused by MSP‐8 Deficiency Determines Fungal Multidrug Resistance with Fitness Cost

Zhou, M., Yu, P., Hu, C., Fang, W., Jin, C., Li, S., & Sun, X. (2024) · Advanced Science · doi:10.1002/advs.202412514 · Cited by 2 · see citing works

A small Candida glabrata protein promotes hyphal growth in C. albicans during mixed-species invasive candidiasis

Parnandi, V. A., Trivedi, P. M., Panchal, H., Suryawanshi, G., & Patkar, R. (2025) · Current Biology · doi:10.1016/j.cub.2025.10.082 · Cited by 1 · see citing works

Dissection of genotype-phenotype relationships in Candida parapsilosis uncovers drivers of clinically-relevant traitsPreprint

Schikora-Tamarit, M. À., López‐Peralta, E., Roldán, A., de Armentia, C., Torres-Cano, A., Alcázar‐Fuoli, L., CAPAR Study Group, Zaragoza, O., & Gabaldón, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.18.725882 · Cited by 1 · see citing works

Anidulafungin/caspofungin/voriconazole

(2019) · Reactions Weekly · doi:10.1007/s40278-019-59199-8

Caspofungin-Based Red-Emissive Probes for Fluorescent Imaging of Pathogenic Fungi

Klausen, M., Sharma, R., Brown, J. L., Ramage, G., & Bradley, M. (2026) · JACS Au · doi:10.1021/jacsau.6c00209

Urosepsis by multidrug-resistant Nakaseomyces glabratus with non-functional Erg3 and Erg11—do collateral sensitivity and a unique mode of action make nitroxoline a viable UTI antifungal?

Carolus, H., Biriukov, V. V., Vreys, J., Romero, C. L., Ávila, J. P. H., Vergauwen, R., Sofras, D., Nysten, J. V., Vanreppelen, G., Vinken, L., et al. (2026) · mBio · doi:10.1128/mbio.00588-26

Environmental and Host Stress Adaptation in Nakaseomyces glabratus: Antifungal Tolerance, Persistence, and Potential Links to Resistance Evolution

Caracciolo, M., Caracciolo, S. A., Stagno, M. F., Papola, C., Pellicano, S., Nicolò, G. M., D’Aleo, F., Ripepi, A., Scopelliti, C., Principe, L., et al. (2026) · Journal of Fungi · doi:10.3390/jof12110802

Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure

Lewis, J. S., Wiederhold, N. P., Wickes, B. L., Patterson, T. F., & Jorgensen, J. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-13 · Cited by 101 · see citing works

Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates

Misas, E., Seagle, E. E., Jenkins, E. N., Rajeev, M., Hurst, S. F., Nunnally, N. S., Bentz, M. L., Lyman, M., Berkow, E. L., Harrison, L. H., et al. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.01140-23 · Cited by 18 · see citing works

Echinocandin-Resistenzen in \(Candida\) \(glabrata\)

Aldejohann, A. M. (2022) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-27584

Microevolution of Candida glabrata (Nakaseomyces glabrata) during an infection

López-Marmolejo, A. L., Hernández-Chávez, M. J., Gutiérrez‐Escobedo, G., Herrera-Basurto, M. S., Mora-Montes, H. M., Peñas, A. D. L., & Castaño, I. (2024) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2024.103891 · Cited by 6 · see citing works

752. Decreased Echinocandin Resistance among Candida glabrata over an Eleven-Year Period at a University Hospital

Raabe, N. J., Zhao, Y., Paderu, P., Shields, R. K., Clancy, C. J., & Nguyen, M. H. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac492.037